Lisa Marsch, PhD
Cynthia Campbell, PhD
This is an observational study designed to (1) evaluate the feasibility and utility of digital health technology in a MOUD treatment population, and (2) capitalize on the availability of EHR data to relate passive and active sensing data to treatment retention and medication adherence. Fifty participants, in active treatment with buprenorphine for OUD, will be recruited from designated recruitment clinics at Kaiser Permanente in Northern California.
Funded by the NIH HEAL InitiativeSM.
- CTN-0084: Developing a Prescription Opioid Registry across Diverse Health Systems
- CTN-0084-A-1: Determining the Optimal Duration of Buprenorphine Treatment to Reduce the Risk of Relapse, Overdose, and Mortality
All Participating Nodes: